Journal logo

How Machine Learning is Helping in Accelerating Drug Discovery?

Machine learning has been effectively proving its worth in the pharmaceutical industry lately.

By Phil StephanPublished 3 years ago 2 min read
machine learning in drug discovery

The discovery of any new drug is often very exciting and thrilling for the academic community as well as for the general public. Drug discovery is very crucial for physical health and wellbeing for the present as well as future generations. It is the right step towards a healthy future and towards curing major illnesses such as oral cancer, mental illness, and much more.

The drug discovery process is often very expensive and takes a lot of time and effort. Approximately, it costs around 4 billion dollars to major pharmaceutical companies to bring a new and effective drug to the market. It may take 10-15 years and the most shocking part is that only 4-5% of the drugs get approved for public usage.

There are many levels of clinical trials before any drug comes to the market. The main goal of this is to test the safety and effectiveness of the new medication. It also determines the right dose and the limits of the new drug.

Additionally, there are volunteers in clinical trials. The person has to go to the clinical site every two or three weeks for checkups and to perform certain measurements to ensure the safety of the drug for the rest of the people. This whole process requires the best balance of potential risks and benefits.

Machine learning has been effectively proving its worth in the pharmaceutical industry. Drug discovery companies usually take a data-driven process that requires a lot of data such as images of the drug, the structure of its compounds, which is quite expensive. One of the key advantages machine learning offers here is cutting down the expenses of the drug development process.

Machine Learning Offers A Good Solution in Accelerating Drug Discovery

Machine learning offers effective access and a better understanding of a large amount of data, along with improving the processes and outcomes. Machine learning can automate all the predictions and experiments. It is said that big data and machine learning in drug development can generate a valuation of around 100 billion dollars in a year.

It also helps with cost and timeframes. Since drugs only work if they bind to the target receptor site in the body (proteins), analyzing that stickiness is the main hurdle. With the new machine learning techniques, it can easily calculate the strength of the binding interaction between the candidate taking the drug and their targets.

As we already discussed above, machine learning does an excellent job in accelerating drug discovery. It has presented a good opportunity to the contract research organizations as well as pharmaceutical companies since these firms invest a lot of time and resources in drug discovery.


In simple words, you can say that drug development is important for future generations as well as the present ones and with the help of machine learning this process has become very effective and less costly and time-consuming. Machine learning is accelerating drug discovery and is life-changing for the drug discovery process. It is making the process much easier now.


About the Creator

Phil Stephan

Strategic content partner and digital marketing specialist at Dignitas Digital

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights


There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment

    Find us on social media

    Miscellaneous links

    • Explore
    • Contact
    • Privacy Policy
    • Terms of Use
    • Support

    © 2024 Creatd, Inc. All Rights Reserved.